Parkinson’s disease (PD) is a neurodegenerative disease that presents several challenges for the treating physicians. Current treatment depends on the patient’s age, disease stage, most troublesome symptoms, the balance between efficacy and risk for each therapeutic, and several other factors. Therefore, it is important to base therapeutic decisions on the best available data for each intervention.
In this regard, The European Federation of Neurological Societies (EFNS) and Movement Disorder Society–European Section (MDS-ES) have summarized guidelines to assist medical professionals in assessing the evidence-based management of Parkinson`s disease (PD). Recommendations for the treatment of early untreated PD The choice of drug depends on the impact of improving motor disability compared with; The risk of motor complications that are more common in younger patients. Neuropsychiatric…
